FDA Expert Panel on Menopause

Big News on Menopause & Hormone Therapy—FDA Panel Recommends Major Changes

This week, a panel of top medical experts convened by the FDA made headlines by calling for major changes to how hormone replacement therapy (HRT) is labeled and understood—especially for women going through menopause.

The panel urged the FDA to revise or remove the long-standing black-box warnings on estrogen therapies that have scared many women and doctors away from safe and effective treatment. In particular, low-dose vaginal estrogen was declared “categorically safe” for all women, with no evidence of systemic risk.

They also highlighted that when started near the time of menopause, systemic HRT may actually reduce heart disease, osteoporosis, and even mortality in some women. The panel called out the urgent need for better menopause education for doctors and advocated for FDA-approved testosterone options for women, too.

This could be a huge step forward in modern, evidence-based menopause care.

👉 Read more and watch the expert panel here: https://www.youtube.com/watch?v=_2ZRlOivC5M